| Toa Pharmaceutical Co., Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20090010902 | TLR4 Transcription Activity Suppressor - The object of the invention is to provide a TLR4 transcription factor activity suppressor which suppresses TLR4 transcription factor and is effective in inducing or maintaining remission of ulcerative colitis. | 01-08-2009 |
| 20090010892 | Hyperlipidemia Treatment Agent - To provide a cholesterolemia treatment agent comprising, as an active ingredient, a bacterial mixture of three bacterial types consisting of lactic acid bacteria, butyric acid bacteria, and glycation bacteria which are effective in lowering serum cholesterol. And to provide a triglyceridemia treatment agent comprising, as an active ingredient, a bacterial mixture of three bacterial types consisting of lactic acid bacteria, butyric acid bacteria, and glycation bacteria which are effective in lowering triglycerides. | 01-08-2009 |
| 20090010891 | Sepsis Treatment Agent - To provide a bacterial translocation preventive for humans and animals comprising a probiotics formulation which has lactic acid bacteria, butyric acid bacteria, and saccharifying bacteria as the main components thereof. And to provide a sepsis treatment agent for humans and animals comprising a probiotics formulation which has lactic acid bacteria, butyric acid bacteria, and saccharifying bacteria as the main components thereof. | 01-08-2009 |
